Kyverna Therapeutics, Inc. (KYTX)
8.23
-0.19
(-2.26%)
USD |
NASDAQ |
Aug 24, 16:00
8.23
0.00 (0.00%)
After-Hours: 20:00
Kyverna Therapeutics Market Cap : 506.72M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 518.42M |
| August 20, 2026 | 500.57M |
| August 19, 2026 | 546.13M |
| August 18, 2026 | 523.35M |
| August 17, 2026 | 551.05M |
| August 14, 2026 | 503.03M |
| August 13, 2026 | 497.49M |
| August 12, 2026 | 495.64M |
| August 11, 2026 | 493.79M |
| August 10, 2026 | 485.79M |
| August 07, 2026 | 490.10M |
| August 06, 2026 | 477.17M |
| August 05, 2026 | 462.47M |
| August 04, 2026 | 470.94M |
| August 03, 2026 | 454.60M |
| July 31, 2026 | 441.89M |
| July 30, 2026 | 453.39M |
| July 29, 2026 | 427.96M |
| July 28, 2026 | 453.39M |
| July 27, 2026 | 479.42M |
| July 24, 2026 | 448.55M |
| July 23, 2026 | 441.28M |
| July 22, 2026 | 447.94M |
| July 21, 2026 | 452.78M |
| July 20, 2026 | 438.26M |
| Date | Value |
|---|---|
| July 17, 2026 | 450.97M |
| July 16, 2026 | 450.36M |
| July 15, 2026 | 470.94M |
| July 14, 2026 | 480.63M |
| July 13, 2026 | 470.34M |
| July 10, 2026 | 513.62M |
| July 09, 2026 | 593.82M |
| July 08, 2026 | 599.88M |
| July 07, 2026 | 585.95M |
| July 06, 2026 | 554.48M |
| July 02, 2026 | 538.13M |
| July 01, 2026 | 510.89M |
| June 30, 2026 | 539.34M |
| June 29, 2026 | 531.48M |
| June 26, 2026 | 510.89M |
| June 25, 2026 | 496.37M |
| June 24, 2026 | 521.79M |
| June 23, 2026 | 510.29M |
| June 22, 2026 | 502.42M |
| June 18, 2026 | 488.50M |
| June 17, 2026 | 486.68M |
| June 16, 2026 | 479.42M |
| June 15, 2026 | 493.34M |
| June 12, 2026 | 487.59M |
| June 11, 2026 | 476.39M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cartesian Therapeutics, Inc. | 305.49M |
| Allogene Therapeutics, Inc. | 702.78M |
| Beam Therapeutics, Inc. | 2.927B |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
Market Cap Related Metrics
| Price to Book Value | 3.061 |
| Price | 8.23 |
| Earnings Yield | -35.67% |